Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19601273 | 0.89 | POLB (0.39) | POLBCYP19A1ALDH1A1PKMGAA | |
| SCHEMBL835434 | 0.85 | CYP19A1 (0.39) | POLBCYP19A1ALDH1A1PKMGAA | |
| SCHEMBL13318048 | 0.84 | CYP19A1 (0.46) | POLBCYP19A1ALDH1A1PKMGAA | |
| SCHEMBL17190592 | 0.83 | ALDH1A1 (0.39) | POLBCYP19A1ALDH1A1PKMGAA | |
| SCHEMBL16307670 | 0.82 | LMNA (0.43) | POLBALDH1A1PKMGAASMN1; SMN2 | |
| SCHEMBL10155348 | 0.82 | POLB (0.36) | POLBCYP19A1ALDH1A1PKMGAA | |
| SCHEMBL20382860 | 0.81 | POLB (0.36) | POLBCYP19A1ALDH1A1PKMGAA | |
| SCHEMBL14328060 | 0.81 | CYP19A1 (0.49) | POLBCYP19A1ALDH1A1PKMSMN1; SMN2 | |
| SCHEMBL12909326 | 0.80 | ALDH1A1 (0.36) | POLBCYP19A1ALDH1A1PKM | |
| SCHEMBL15497855 | 0.79 | ALDH1A1 (0.44) | ALDH1A1PKMMAPK1HTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230038373-A1 | STABILE CONJUGATE | GLYKOS BIOMEDICAL OY (FI) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230038373-A1 | STABILE CONJUGATE | CD2, TTL, DDOST | POLB 2836/4885CYP19A1 2347/4885ALDH1A1 527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.